Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spirit Scientific CoROCO:7790 +0.77%21 EBITDA Margin % is 14.88% as of Dec. 2025, which is 6% below its 10-year median of 15.91. GuruFocus rates ROCO:7790 with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 939 Biotechnology companies, Spirit Scientific Co ranks better than 79.98% on this metric.
Spirit Scientific Co (ROCO:7790) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Spirit Scientific Co EBITDA Margin % Related Terms
Spirit Scientific Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Spirit Scientific Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7790 vs VRTX, REGN, ALNY: EBITDA Margin % Comparison
For the Biotechnology subindustry, Spirit Scientific Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spirit Scientific Co EBITDA Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Spirit Scientific Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Spirit Scientific Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spirit Scientific Co (ROCO:7790) has a EBITDA Margin % of 14.88% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Spirit Scientific Co and its competitors. This is near median its historical median of 15.91. Over the past decade, Spirit Scientific Co's EBITDA Margin % has ranged from 5.37 to 20.62. According to the industry distribution chart, Spirit Scientific Co ranks #188 out of 939 companies in the Biotechnology industry, placing it in the top 20%.
Is Spirit Scientific Co's EBITDA Margin % too high?
Spirit Scientific Co's current EBITDA Margin % of 14.88% is near median its 10-year median of 15.91. Over the past 10 years, this metric has ranged from a low of 5.37 to a high of 20.62. Based on the distribution chart, Spirit Scientific Co ranks #188 out of 939 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Spirit Scientific Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Spirit Scientific Co's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Spirit Scientific Co ranks #188 out of 939 companies for EBITDA Margin %. This places Spirit Scientific Co in the top 20% of its industry — outperforming the majority of peers. Historically, Spirit Scientific Co's own EBITDA Margin % has ranged from 5.37 to 20.62 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Spirit Scientific Co and its competitors. Spirit Scientific Co's current EBITDA Margin % is 14.88%, which is near median its own 10-year median of 15.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spirit Scientific Co stock overvalued right now?
Spirit Scientific Co (ROCO:7790) has a current EBITDA Margin % of 14.88%. The current EBITDA Margin % is 14.88%, which is near median its 10-year median of 15.91. Spirit Scientific Co's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Spirit Scientific Co (ROCO:7790), the current EBITDA Margin % is 14.88% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Spirit Scientific Co Ltd is engaged in precision regenerative medicine, specializing in platelet cryocrystallization technology and Bio Material Lyophilized Technology (BMLT). The company provides solutions for extracting high-concentration platelet growth factors, enabling safe, flexible, and long-term storage therapies. Spirit Biotech delivers cutting-edge autologous healing reagent preparation services, along with OEM and ODM models. With a focus on unmet medical needs, the company transforms patented technologies into scalable solutions, advancing the future of regenerative healthcare.
21GF Score
Get the complete analysis for ROCO:7790
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7790 has been successfully added to your 
